InflaRx (IFRX) Selling, General & Administrative (2016 - 2026)
InflaRx's Selling, General & Administrative came in at -$2.96 million for Q2 2026, compared with -$3.71 million a year earlier.
Powered by 
Analysis
InflaRx (IFRX) Selling, General & Administrative (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, InflaRx reported Selling, General & Administrative of -$15.69 trillion; for FY2025, it was -$15.22 trillion.
- Going back by year, Selling, General & Administrative was -$13.92 trillion in FY2024, -$13.59 trillion in FY2023, -$15.17 trillion in FY2022 and -$13.71 trillion in FY2021.
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative since Q3 2020.
- Business Quant data shows IFRX's Selling, General & Administrative at -$3.72 million (Q1 2026), -$15.69 trillion (Q4 2025) and -$3.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 3.41 Bn |
| 10 | InflaRx | 102.28 Mn | -231.34 Mn | 2.74 Mn | -2.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.96 Mn |
| Mar 31, 2026 | -3.72 Mn |
| Dec 31, 2025 | 28.44 Mn |
| Sep 30, 2025 | -3.06 Mn |
| Jun 30, 2025 | -3.71 Mn |
| Mar 31, 2025 | -5.33 Mn |
| Dec 31, 2024 | 24.19 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -3.47 Mn |
| Mar 31, 2024 | -3.89 Mn |
| Dec 31, 2023 | 24.40 Mn |
| Sep 30, 2023 | -3.15 Mn |
| Jun 30, 2023 | -3.86 Mn |
| Mar 31, 2023 | -3.87 Mn |
| Dec 31, 2022 | 27.23 Mn |
| Sep 30, 2022 | -3.11 Mn |
| Jun 30, 2022 | 4.64 Mn |
| Mar 31, 2022 | -4.92 Mn |
| Dec 31, 2021 | 24.14 Mn |
| Sep 30, 2021 | -4.00 Mn |
API Access
InflaRx Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();